Mutations affecting the proal(I) or proa2(I) collagen genes have been identified in each of the major clinical types of osteogenesis imperfecta. This study reports the presence of a heritable connective tissue disorder in a family with an osteopenic syndrome which has features of mild osteogenesis imperfecta but was considered idiopathic osteoporosis in the proband. At age 38, while still premenopausal, she was found to have osteopenia, short stature, hypermobile joints, mild hyperelastic skin, mild scoliosis, and blue sclerae. There was no history of vertebral or appendicular fracture. Hip and vertebral bone mineral density measurements were consistent with marked fracture risk. Delayed reduction SDS-PAGE of pepsin-digested collagens from dermal fibroblast cultures demonstrated an anomalous band migrating between al(I) and al(III). This band merged with the normal a-chains upon prereduction, indicating an unexpected cysteine residue. Cyanogen bromide peptide mapping suggested that the mutation was in the smaller NH2-terminal peptides. cDNA was reverse transcribed from mRNA and amplified by the polymerase chain reaction. A basepair mismatch between proband and control al(I) cDNA hybrids was detected by chemical cleavage with hydroxylamine:piperidine. The cysteine substitution was thus localized to al(I) exon 9 within the cyanogen bromide 4 peptide. Nucleotide sequence analysis localized a G -* T point mutation in the first position of helical codon 43, replacing the expected glycine (GGT) residue with a cysteine (TGT). The prevalence of similar NH2-terminal mutations in subjects with this phenotype which clinically overlaps idiopathic osteoporosis remains to be determined. (J. Clin. Invest. 1992.
Introduction
Osteogenesis imperfecta (01)' has been subdivided into four major clinical types ofdisease based on clinical severity, inheri-tance, and scleral color (1) . However, it is recognized that these different phenotypes represent a continuum ofdisease severity.
Toward the mild end ofthe spectrum it is frequently difficult to distinguish patients with mild 01 type I from certain patients with idiopathic osteoporosis who present a family history of osteoporosis and fractures (2) (3) (4) . These individuals may also have variable degrees of joint laxity and mild scoliosis. Blue sclerae are characteristic of 01 type I, but this also occurs in other connective tissue disorders, as well as in otherwise normal individuals (5) .
Most individuals with 01 have mutations that affect the synthesis of type I collagen, the main structural protein of bone, tendon, and skin (6) . Clinically, the overlap offindings in mild 01 and idiopathic osteoporosis suggests that similar defects in type I collagen might be found in some osteopenic individuals whose mild skeletal disorder differs from that expected in subjects with O.
The basic unit ofthe type I collagen triple helix is the triplet (Gly-X-Y)n, in which the repeat of the first position glycine is essential to the unique triple helical structure. Mutations involving the primary structure of the type I collagen gene may result in amino acid substitutions, insertions, deletions, mRNA splicing defects, and/or alterations in protein posttranslational modification (6) . First position glycine substitutions have been recognized to account for the majority of OI cases reported (7) . Point mutations in the first position of the glycine codon (GGN, where N can be any nucleotide) will change that residue to either cysteine (G -* T), arginine (G -) C), or serine (G -> A). On the other hand, a cysteine residue in the X or Y position could result from a single base substitution in the codons for glycine, arginine, phenylalanine, or serine. A characteristic disulfide-linked dimer, easily recognizable on SDS-PAGE, is formed when two proa I(I) chains containing a cysteine mutation associate with a normal proa2(I) chain. The impact of a cysteine substitution on skeletal matrix development will vary with the location of the mutation, i.e., either within or outside of the triple helical domain or toward the COOH or NH2 terminus (7) . This report describes a woman with an osteopenic syndrome consistent with mild 01 type I, but in whom ascertainment was based on a diagnosis of idiopathic osteoporosis. She and her two affected children have never experienced fractures. The biochemical defect is a glycine 43 to cysteine mutation in one allele of a 1(I) collagen, located near the NH2 terminus of the molecule in exon 9 (within cyanogen bromide [CB] peptide 4). We believe that patients presenting with this particular osteoporotic phenotype should be studied for type I collagen defects, particularly NH2-terminal mutations that would be predicted to have less severe consequences on collagen matrix development and skeletal formation.
Methods
Case report. The pedigree for this family is presented in Fig. 1 . The proband (11-2, see arrow) was a 38-yr-old female whose clinical history includes joint laxity, dislocations of her shoulder, multiple ankle sprains, and a tear of her bladder and uterus during her last delivery. Significantly, there was no history of fractures. Menstrual history was normal. Physical examination revealed short stature (151 cm), blue sclerae, and joint laxity. There was no dentinogenesis imperfecta, scoliosis, or deformity of her limbs. The diagnosis of osteoporosis was based on osteopenia of the thoracic vertebrae initially seen on routine lateral chest x rays. Osteopenia was confirmed by dual photon densitometry ofthe lumbar vertebrae and hip. Mean vertebral bone mineral density (BMD) of L2-L4 was 0.792 g/cm2 or 69% of age-and sexmatched normal controls. Mean femur (Wards's triangle) BMD was 0.650 g/cm2 or 66% of age-and sex-matched normal controls. Normal control BMD values were those of the Oschner Clinic using a dual photon scanner (Lunar Co., Madison, WI) with a Gadolinium-153 source. These values are two standard deviations below that for ageand sex-matched normal controls and are consistent with marked fracture risk (8) .
Two ofher four children (Fig. 1 , III-1 and 111-4) share the phenotype of short stature (both were less than the fifth age adjusted percentile in height), joint laxity, dislocations, and blue sclerae. III-1 also had scoliosis. These two children had mean BMD in L2-L4 of 0.605 and 0.442, respectively. These values are two standard deviations below that for young normal controls and are consistent with marked fracture risk (9) . Neither of these children had experienced a fracture in spite of normal physical activity. The [ '4C]proline-labeled samples were subjected to limited pepsin digestion (10 gg/ ml pepsin for 6 h at 40C) followed by 2 M NaCI precipitation and 7.5% SDS-PAGE in either the unreduced condition, prereduced with DTT, or with delayed reduction (11) . Two-dimensional 7.5% SDS-PAGE was performed with delayed reduction in the first dimension, followed by DTT prereduction before the second dimension 7.5% SDS-PAGE (12) . Both dimensions were 7.5% SDS-PAGE. Individual collagen achains were peptide mapped by in situ CB digestion and 10-15% gradient SDS-PAGE in the unreduced and reduced states (12) . Autoradiographs of the radiolabeled collagens were analyzed by scanning densitometry (13) . Type I collagen triple helix thermal stability was determined by the method of Bruckner and Prockop (14) . mRNA isolation. Total fibroblast RNA from the proband and a control was isolated from confluent cell layers that had been treated for 24 h with ascorbate. The cell layer was then harvested in 1% SDS, 1 mM EDTA, 50 mM Tris, pH 7.5, buffer containing 100 ,ug/ml proteinase K. The sample was incubated at 37°C for 60 min followed by phenol/chloroform extraction and ethanol precipitation ofthe nucleic acids (15) . The nucleic acid pellet was solubilized in 6 M guanidine-HC1 and the RNA separated from the DNA by selective precipitation with 0.5 vol of ethanol. The RNA was sequentially washed in 4 M guanidine/33% ethanol, then 80% ethanol, dried in a vacuum (Speedvac SC100; Savant Instruments, Farmingdale, NY), redissolved in H20, and stored at -70°C.
mRNA reverse transcription to cDNA. al(I) fibroblast mRNA was isolated from the proband and a control, and then reverse transcribed to cDNA using a 35-mer primer (3'-GG GAG TTC TCG GAC TCG GTC GTC TAG CTC TTG TAG-5') complementary to the COOHterminal propeptide (nucleotides 3,820-3,854). This fragment is located 46 nucleotides 3' to the C-propeptide cleavage site. Approximately 5 Mg of total RNA was added to 2.5 Mg of oligonucleotide; the sample was heated to 65°C for 3 min and then cooled on ice. The volume was then adjusted to 50 ,l final volume with 50 mM Tris, pH 8.3, 75 mM KCG, 3 mM MgCl2, 10 mM DTT, and 500 AM dNTPs.
First strand cDNAs were synthesized by the addition of 450 U of Maloney murine leukemia virus reverse transcriptase (Life Technologies, Inc.) followed by incubation for 60 min at 37°C (16).
Polymerase chain reaction cDNA amplification. For polymerase chain reaction (PCR) amplification of the cDNA, -5 Ml of the cDNA synthesis reaction was mixed with 100 pmol ofeach oftwo oligonucleotides that flanked the nucleotide sequence of interest. The upstream oligonucleotide (5'-TCA TGA CAT CTA GAC TTT GCT CCC CAG CTG CTG TCT TAT G-3') was derived from exon 6, while the downstream oligonucleotide (5'-CGA GCA CCT TTA CTA CCA CGA TGA CCT AGG TCA CTG AT-3') was derived from exon 15. These primers were designed to yield a cDNA of 538 bp in length, spanning exons 6-15. The sample was diluted to 100 Ml with 16.6 mM ammo-nium acetate, 67 mM Tris-HCl, pH 8.8, 6.7 mM MgCl2, 10 mM ,Bmercaptoethanol, 6.7 MM EDTA, 33 uM dNTPs, and 1.5 U of Thermus aquaticus DNA polymerase (Perkin-Elmer Cetus, Emeryville, CA) was added and the reaction was run in a thermalcycler (17) . After an initial denaturation at 940C for 5 min, 30 cycles were run with 1 min denaturation at 930C, 1 min annealing at 620C, and 1 min polymerization at 720C, followed by final extension at 720C for 7 min.
Chemical cleavage ofcDNA heteroduplexes. The products of each PCR reaction were examined in a 5% Tris/borate/EDTA/polyacrylamide minigel and the resulting exon 6-15 cDNA was electroeluted. The purified 6-15 exon cDNA fragment from wild-type cDNA was 3p end-labeled using T4 DNA polymerase (18) . Approximately 10 ng (106 cpm) of the wild-type cDNA probe was mixed with 120 ng ofthe exon 6-15 cDNA fragment from the proband or an equal quantity of unlabeled, control exon 6-15 cDNA fragment. The final volume was 50 Ml of 300 mM NaCl, 3 mM Tris, pH 7.7, and 3.5 mM MgCl2. The sample was boiled for 5 min and allowed to anneal for 60 min at 420C to form a cDNA heteroduplex. The sample was then precipitated with ethanol, redissolved in 18 Ml H20, and divided into three 6-Ml aliquots before the chemical cleavage procedure (19 and al(I) under unreduced and delayed reduction conditions. The Std is chick type I collagen standard and C is a normal age-and sexmatched control. ing, anomalous band (Fig. 2, -DTT) . This band was observed to merge with the normal a-chains upon prereduction of the sample with DTT (Fig. 2, +DTT) . It was noted to be independent from a 1(111) when DTT was added after the tracking dye had migrated one-third of the way through the gel (Fig. 2 , delayed reduction). Since normal type I collagen a-chains do not contain cysteine, these data indicated the presence ofa cysteine residue within the triple helical domain ofthe proband's type I collagen, here referred to as a 1 (cys)2. An identical electrophoretic pattern, with the same anomalous band, was observed upon repeating these SDS-PAGE analyses with pepsin-purified collagen from dermal fibroblasts isolated from the two affected children (data not shown). Densitometric analysis of the delayed reduced gel (Fig. 2 , delayed +DTT) demonstrated that a normal ratio of a l(I)/ a2(I) and a l(III)/al(I) was obtained when the scan values for the al(cys)2 band were added to the a 1(I) band (Table I) . As- suming that intracellular degradation of the mutant a I(I) was not significant, the theoretical ratio for al(I):a2(I):al(cys)2 as predicted by Steinmann et al. for such a mutation would be 3:2:1 (26) . Indeed, the observed ratio for the proband was 1:0.64:0.31, indicating that (a) the al(cys)2 dimer formation occurred during chain assembly, (b) a-chain synthesis in these cells was balanced, and (c) one of the two alleles carried the mutation. Two-dimensional 7.5% SDS-PAGE with delayed reduction in the first dimension demonstrated that al(cys)2 comigrated with normal a(I) when fully reduced in the second dimension (data not shown). These data indicated that the a l(cys)2 is consistent with a cysteine containing a 1(I) polypeptide chain.
Incubation of type I collagen a-chains with cyanogen bromide selectively cleaves the polypeptides on the COOH side of methionine residues. This pattern ofCB peptides has been well characterized (12) . The three species of a-chains were separated by delayed reduction 7.5% SDS-PAGE followed by in situ cleavage with CB. The CB peptides were resolved by 10-15% gradient SDS-PAGE without DTT. The CB map obtained from al(cys)2 demonstrates a normal pattern of the a1(I) CB peptides 8, 3, 7, and 6 (Fig. 3) . However, the presence ofhigher molecular weight, partially cleaved CB peptides was also ob- served (see arrows). These data suggested that the cysteine mutation was localized in the smaller fragments derived from the NH2-terminal region of the triple helix (Fig. 3, diagram below  figure) . These smaller, NH2-terminal al(I) CB peptides 1, 2, 4, and 5 are not retained even in 10-15% gradient SDS-PAGE. However, the partially digested CB peptides would be expected to demonstrate abnormal mobility due to the cysteine dimerization of the partially cleaved CB fragments. Molecular analysis. PCR amplification of cDNAs derived from fibroblast mRNA was used to further examine the area of interest in the proband's al(I) gene. The a 1(I) helical domain begins at exon 6. The CB peptides 1, 2, 4, and 5 are encoded by exons 6, 7-8, 9-1 1, and 12-13, respectively. We selected oligonucleotides that flanked exons 6-15 in order to amplify a 538-bp cDNA that had been reverse transcribed from proband and control fibroblasts. Since the hydroxylamine modification:piperidine cleavage method described by Cotton et al. cleaves mismatched cytosine nucleotides in cDNA heteroduplexes, hybridization of radiolabeled wild-type cDNA probes to the proband's cDNA would be expected to detect a mutated guanosine residue in the coding strand (19) . Fig. 4 Protein structural analysis. The impact ofthis mutation on the type I collagen triple helix was studied by the determination of thermal stability. The thermal stability oftotal (normal plus disulfide bonded) collagen triple helix was measured subsequent to isolation by limited pepsin digestion. Fig. 6 demonstrates the thermal stability versus incubation temperature, with these data expressed as a percentage of a sham incubated control. In the control fibroblasts the curve was shifted slightly to the left and Tm(50%) was 40'C versus 41.30C, indicating a small decrease in thermal stability of the type I collagen triple helix.
Discussion
During the past 15 years studies from several laboratories (7, 20) blue sclerae, and joint laxity. (25) . A serine for glycine substitution in triple helix amino acid position 661 was detected in the a2(I) chain. While clinically this patient probably represents mild OI type I that presumably escaped diagnosis at a younger age, the interesting feature is that skeletal disease of a mild nature can result from a mutation near the COOH terminus. In contrast to NH2-terminal mutations, those near the COOH terminus are considered to cause more disruption of normal triple helix assembly and consequently result in more severe skeletal disease. However, an additional exception is the glycine to cysteine mutation described by Steinmann et al. (26) . The mild nature of the disease in their subject was initially considered to be due to a cysteine mutation in the X or Y position of the (Gly-X-Y). triplet. This mutation was subsequently localized by Cohn et al. and Labhard et al. to amino acid 1,017, within the COOH telopeptide region of the al(I) chain (27, 28) .
Cysteine for glycine substitutions in the a 1 chain of type I collagen of OI patients have been readily detected on SDS-PAGE because dimerization, secondary to disulfide bridge formation, occurs when the heterotrimer contain two mutant chains. This slows the electrophoretic migration of the molecule. Mutations in the a2(I) chain are less easily detected. First position cysteine mutations in the a 1(I) chain resulting in mild OI have been reported at al(I) amino acid 94 (29) and a (I) 175 (30) . Cysteine mutations have also been found in severe 01 type III at al(I) 415 (29) , 526 (29) , and in the lethal 01 type II at al(I) 988 (27) , 748 (31) , 904 (32) , and 718 (29) . In contrast to the mild disease with a COOH-terminal a2(I) serine for glycine substitution described by Spotila et al. (25) these cases appear to support the postulate of more severe disease with a COOHterminal mutation.
The impact of cysteine mutations on the assembly of the procollagen triple helix and subsequent development of the extracellular matrix is not well understood. Traub 
